After weeks of speculation of how exactly another established alcohol company would dip into the cannabis space, on Wednesday (August 1) Molson Coors Brewing (NYSE:TAP; TSX:TPX) and The Hydropothecary Corporation (TSX:HEXO) confirmed a new partnership.

A joint venture will be developed between the two companies for the production of non-alcoholic beverages infused with cannabis. According to the announcement this new venture will be a standalone company with its own executive team and board of directors.


The split between the two companies’ controlling stake in the new venture is 57.5 percent for Molson and the remaining 42.5 percent for Hydropothecary, a company which recently graduated into the Toronto Stock Exchange (TSX).

The company is also in the process of changing its name to HEXO, the name of its cannabis brand.

Sebastien St-Louis, CEO of the cannabis producer said the two Quebec-based companies will begin working on the development of “responsible, high-quality cannabis-infused beverages.”

Canada is set to legalize the sale of recreational cannabis on October 17; however, edibles and other novel items like infused products will have to wait to enter the market.

Frederic Landtmeters, president and CEO of Molson Coors Canada said in a statement the company remains a beer business at the core but also enters the cannabis space through this new venture.

The entry of alcohol companies into the cannabis space

Last year the cannabis sector saw a pop industry wide following the announcement of an investment deal for Constellation Brands (NYSE:STZ), an alcohol producer behind Corona beer and Svedka Vodka into Canopy Growth (TSX:WEED; NYSE:CGC).

The deal represented an investment of approximately C$245 million into the leading cannabis company for a 9.9 percent interest. Since then Bruce Linton, CEO of Canopy, has indicated the two companies meet regularly and have a key interest in their own infused beverage products.

A variety of consumer studies have started to show the trend of alcohol consumption dropping in territories where cannabis becomes legal. A recent joint research study found over ten studied years, between 2006 and 2015, counties with legal medical cannabis caused a nearly 15 percent dip for alcohol sales per month.

Despite these predictions, the alcohol industry has embraced the potential of the cannabis space with the Wine & Spirits Wholesalers of America (WSWA) voicing their support for the legalization of adult-use cannabis in the US.

The association offered its support for the cause and even offered regulations it wishes to see in place for the legalization of the drug, like a minimum consumption and possession age of 21-years-old.

Investor takeaway

The share price for HEXO rose quickly on Wednesday’s trading session, reaching a price of C$4.94, a near 14 percent increase as of 1:40 p.m. EST.

Molson’s New York Stock Exchange (NYSE) stock also enjoyed a substantial increase on Wednesday as its share price rose 5.45 percent to reach a price tag of US$70.18.

The cannabis producer currently holds a favourable “Moderate Buy” rating on the analyst data aggregator site TipRanks, with the latest report issued today from Matt Bottomley at Canaccord Genuity.

Bottomley gave the company a “Buy” rating and stamped the company with a C$7.50 price target for one year. The average analyst price target for HEXO is C$7.13, equaling a 44.48 percent upside.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less

Company establishes bit mining infrastructure for long term revenue generation

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is pleased to announce that it has signed a $2.5 million (USD) definitive agreement as of January 14th, 2021, to acquire bit mining infrastructure based in the USA for long term revenue generation

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it is commencing a best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company.

Keep reading... Show less